Sunday, April 3, 2011
Bubble gum with high levels of Lead recalled by FDA
With each passing day, we come across companies recalling their products so that it cannot harm humans in anyway. Now we heard that the Food and Drug Administration of the US have decided to recall Toxic Waste Short Circuits Bubble Gum because according to them, it contains elevated amounts of lead that can affect the health of humans. When the amounts of lead are more, it could harm the health of children, infants and women who are pregnant. This bubble gum is being imported from Pakistan and is being marketed by Candy Dynamics. They themselves have asked for its recall. The FDA recently conducted a test on this gum and they found out that the levels of lead in it are 0.189 parts per million and the FDA tolerates only upto 0.1 ppm. Its size is 32 oz and it was distributed from January this year. So far, no illness has come to the light following the usage of the bubble gum. Candy Dynamics are now urging the people to destroy the product by calling at 317-228-5012. This is certainly a good move by the FDA because they want to risk the lives of the people by approving a gum which has a high concentration of lead. This product is being sold at retailers in Michigan and other parts of the US. It is also available in Canada. The bubble gum was imported through mail order. The company manufacturer’s now have some serious thinking to do about the gum. McNeil Called Off Tylenol, Motrin and Zyrtec; Use Generic FDA Pulls back the Medtronic Pump fill
Subscribe to:
Post Comments (Atom)
- Female Sexual Dysfunction Drug Fails to Reach Market
- Legal Action Over FDA by US Cigarette Companies
- FDA says TNF blockers can lead to Blood Cancer
- Bubble gum with high levels of Lead recalled by FDA
- Artificial Womb
- Astrocytes Identified as Depression Therapy
- Weight Loss Surgery Helps Avoid Heart Disease in Youngsters
- Transcranial Magnetic Stimulation For Treating Depression
- Obesity Raises Odds Of Acne in Teenagers
- Ovaries Transplantation: Menopause and Pregnancy At Your Wish
- Depomed May Lose Exclusive Rigths on Gralise
- Zioptan, FDA Approved Treatment for Glaucoma
- Embryos Growth Could Pedict Risk In Pregnancy
- Sanofi and Selecta to Develop Food Allergy Treatment
- FDA Safety Warning: Blood Clot Risk with Drospirenone Contraceptives
- FDA Warning: France T253, Stree Overlord, AfricanBlackAnt
- Sexual Dysfunction Likely in Women after Dialysis, says Studies
No comments:
Post a Comment